This page is available in multiple languages
Select Language

SMAIO lists on Euronext Growth Paris

Back

  • €8.9 million raised
  • Market capitalisation of €29 million
  • 4th listing of an innovative healthcare company on Euronext Paris in 2022
  • 9th listing on Euronext Paris in 2022
  • 23rd listing on Euronext in 2022

Paris – 6 April 2022 – Euronext today congratulates SMAIO, a healthcare company specialised in complex spinal surgery, on its listing on Euronext Growth Paris (ticker code: ALSMA).

SMAIO (Software, Machines and Adaptative Implants in Orthopaedics) is a Lyon-based company dedicated to the design, manufacturing and marketing of a range of software, implantable devices and services associated with spinal surgery. A pioneer in the use of data to treat spinal pathologies, SMAIO has developed KEOPS, its Big Data management software, which has become a worldwide reference with more than 100,000 patient cases listed. Building on this wide base, SMAIO offers spine surgeons a complete platform of solutions, I-Kontrol, integrating planning, implantable devices and associated services, which enables them to treat spinal pathologies in an efficient, safe and sustainable manner. Following SMAIO's Initial Public Offering (IPO), which includes an investment agreement with NuVasive, a global leader in technological innovations for the spine, it intends to expand the company's business development, particularly in the United States, and to accelerate the execution of its research and development projects in order to strengthen its position in the spinal surgery market, and to pave the way for industrial collaborations to ultimately move towards active robotics and the progressive automation of spinal surgery.

SMAIO was listed through the admission to trading on 6 April 2022 of the 5,228,651 shares making up its equity and of 1,614,195 new shares issued under a Global Offering[1].

The admission and issue price of SMAIO shares was set at €5.54 per share. Market capitalisation was €29 million on the day of listing. The IPO raised €8.9 million altogether.

Philippe Roussouly, Chief Executive Officer of SMAIO, said: “Our IPO is a major milestone for SMAIO, which aims to establish a new paradigm in spine surgery. SMAIO's differentiated approach, with cutting-edge use of data to treat spinal pathologies and innovative in the field of surgical planning, allows for tailor-made surgery and an optimal, sustainable patient balance. Positioned in a fast-growing market, driven by the need for efficient and reliable solutions, SMAIO's IPO, with the support of its partner NuVasive, aims to accelerate its commercial development, particularly in the United States, the world's largest spine market, while exploiting the immense potential of its database and customised surgical technologies, which will eventually pave the way for active robotics and the progressive automation of spinal surgery.

SMAIO - Euronext Growth Paris

Caption: Philippe Roussouly, CEO of SMAIO, and his team rang the bell during a ceremony this morning, in the presence of Guillaume Morelli, Director Listing SME France at Euronext, to celebrate the IPO of the company.

About SMAIO A leader in the use of clinical data and imaging of the spine, SMAIO designs global solutions for spine surgery specialists. The Company has recognized expertise thanks to KEOPS, its Big Data management software that has become a global reference with more than 100,000 patient cases documented. SMAIO offers spine surgeons a comprehensive platform, I-Kontrol, incorporating planning, implants and related services, enabling them to treat spinal pathologies in a safe, effective and lasting way. SMAIO is positioned at the forefront of innovation with the ambition of providing surgeons with the first active robotic solution enabling a high level of performance and repeatability to be systematically achieved. Based in Lyon, France, SMAIO benefits from the skill and expertise of more than 30 highly specialized staff. For further information, please visit our website: www.smaio.com

 

[1] The Global Offering was made up of a Public Offering that included a Closed Price Public Offering and a Global Placement with institutional investors in France and other countries.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 2,000 listed issuers and around €5.8 trillion in market capitalisation as of end June 2022, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2022, Euronext N.V. - All rights reserved.